First Bancorp Inc ME acquired a new position in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 5,509 shares of the company’s stock, valued at approximately $708,000.
Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Gables Capital Management Inc. acquired a new stake in shares of Merck KGaA in the 2nd quarter valued at about $2,095,000. Diversify Advisory Services LLC acquired a new position in Merck KGaA in the second quarter worth about $3,810,000. Danske Bank A S bought a new stake in Merck KGaA in the second quarter valued at about $276,535,000. Danica Pension Livsforsikringsaktieselskab bought a new stake in Merck KGaA in the second quarter valued at about $25,541,000. Finally, BOK Financial Private Wealth Inc. acquired a new stake in Merck KGaA during the second quarter valued at approximately $523,000. Institutional investors own 0.10% of the company’s stock.
Merck KGaA Trading Up 0.3%
OTCMKTS:MKGAF opened at $164.00 on Wednesday. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. The business’s 50 day moving average is $163.08 and its two-hundred day moving average is $148.69. Merck KGaA has a 52 week low of $116.68 and a 52 week high of $175.56. The company has a market cap of $21.20 billion, a PE ratio of 25.04 and a beta of 0.96.
Merck KGaA Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Further Reading
- Five stocks we like better than Merck KGaA
- Pathward’s Credit Scare Tests Its Comeback Story
- Wiring the AI Boom: Rumble’s $13.7B Pivot
- StoneX: Too Far Too Fast?
- DICK’s Sporting Goods Faces Pain Now for a Bigger Prize
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
